FDA approves first sublingual allergen extract for the treatment of certain …

FDA approves first sublingual allergen extract for the treatment of certain …

The U.S. Food and Drug Administration recently approved Oralair to treat allergic rhinitis (hay fever) with or without conjunctivitis (eye inflammation) that is induced by certain grass pollens in people ages 10 through 65 years. Oralair is the first

2
Like
Save

Comments

Write a comment

*